Packaging and Distribution

The company announced it will be unveiling a new name, Jones Healthcare Group, and a new corporate logo as it celebrates 100 years in the health and wellness markets.

Tracking and implementing label changes are crucial to the lifecycle of a marketed drug product.

Pharmaceutical companies work toward a circular economy by using sustainable packaging.

As a new decade has begun, this editorial reviews some of the biggest, brightest, and boldest happenings from the industry over the past 10 years.

Regulatory mandates, niche diseases, and patient-centric solutions have all impacted pharma packaging over the years and are expected to help shape the future of the sector.

A selection of interesting conferences, technical presentations, and Learning Lab presentations as chosen by the editorial team of Pharmaceutical Technology Europe.

PTE looks ahead to 2020’s edition of Pharmapack-the pharma industry’s dedicated packaging and drug delivery event.

A coalition establishes a secure, direct link between a physical tablet and a digital backend for supply chain integrity.

The new technical service center at the Memphis International Airport will service inbound and outbound traffic for the company’s CSafe RKN and CSafe RAP active container systems.

Trends affecting primary pharmaceutical packaging include the shift to more complex drug-device combination products.

Xcelerate Development Services are complete solution services focused on de-risking development and ensuring speed-to-market.

The plant in Singen, Germany will be used for formulation, filling, and packaging of Takeda’s vaccine candidate.

Schott will combine its adaptiQ platform with West’s Ready Pack system.

The approval marks the first time a new glass composition has been approved by FDA since the approval of borosilicate glass more than 100 years ago.

The packaging solution works to protect drugs with a 3-Phase Activ-Polymer solution, a technology that is customized for the drug developer’s formulation, offers a broad spectrum of specific drug protection, and oxygen and odor scavenging.

Advanced packaging requirements for parenteral drugs are being met with highly tailored solutions.

The company will debut its new brand name, ALPLApharma, and its new childproof closure, the CRC justONE, at CPhI Worldwide from Nov. 5–7 in Frankfurt, Germany.

The new location was established to ensure uninterrupted support for clients’ trials in both the United Kingdom and Europe if the UK leaves the European Union on Oct. 31, 2019, especially in the event of a no-deal Brexit.

Ready-to-use components help compounders and manufacturers of small batches overcome economy-of-scale limitations in aseptic GMP manufacturing.

A complete understanding of primary packaging physicochemical properties is necessary in the formulation and development of biologics.

The companies will present the SV model a semi-automatic machine for the inspection of liquid, lyophilized, or powder products in ampoules, vials, cartridges, and pre-filled syringes.

The new Flexi-Cap Prime will be presented at CPhI Worldwide in Frankfurt, Germany, on Nov. 5–7.

The companies will be presenting Push Packs at CPhI Worldwide on Nov. 5–7 in Frankfurt, Germany.

On Wednesday Nov. 6, 2019, Gregor Deutschle and Dr. Nicolas Eon, both from Schott, will share insights into ready-to-use solutions for complex biotech drugs.

The company will present its solutions to reduce procurement costs for customers and help them bring their products to market faster.

Advances in fill/finish for parenteral packaging address demands for efficiency and product safety.

Automated, electronic systems for raw materials tracking improve efficiency and prevent mistakes in biopharma manufacturing.

The company will supply its heparin sodium injection in prefilled syringe form.

Gerresheimer has announced it will be expanding its ClearJect product line of pre-fillable syringes with a new 2.25-mL cyclic olefin polymer (COP) staked in needle (SIN) syringe.

Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.